SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA FLASH L impact

InMed Pharmaceuticals Completes Merger With Mentari Therapeutics

InMed Pharmaceuticals said it completed its merger with Mentari Therapeutics. Shares are expected to begin trading on Nasdaq under ticker MTRI on November 9, 2026.

INM
SquawkNews Desk 1 updates Updated Nov 06, 2026, 09:07 PM UTC

Story updates

09:07:45 PM UTC
SquawkNews
InMed Pharmaceuticals Completes Merger With Mentari Therapeutics

Related stories

Tang Proposes Buyout of X Financial With 47.97% Stake Yue (Justin) Tang reported beneficial ownership of 47.97% of X Financial and disclosed that Mangrove Coast Investment Limited proposed buying shares it does not already own. The pr L impact | MNA | Nov 06, 2026, 09:47 PM UTC European Commission Approves AkzoNobel–Axalta Merger The European Commission approved the merger of equals between AkzoNobel and Axalta. M impact | MNA | Nov 06, 2026, 08:26 PM UTC Crusoe Says Google Acquired Its Southeast Wyoming Data Center Site L impact | MNA | Nov 06, 2026, 07:36 PM UTC Iveco Offeror Reaches 96.29% Stake, Plans Squeeze-Out Provisional tender-offer results put the offeror’s holding at approximately 96.29% of Iveco Group’s common share capital, net of treasury shares. A Dutch legal squeeze-out will com M impact | MNA | Nov 06, 2026, 06:51 PM UTC New Amsterdam to Buy 100% of Tamiami Investments 2 M impact | MNA | Nov 06, 2026, 06:32 PM UTC Marvell Plans $115 Billion Acquisition of Lumentum Marvell said Monday it plans to acquire Lumentum at a valuation of $115 billion. Both stocks were on pace for historically poor weekly performances by Friday. H impact | MNA | Nov 06, 2026, 06:32 PM UTC